查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1718229

Fentanyl市场 - 全球预测 2025-2030

Fentanyl Market by Product Type, Route of Administration, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年Fentanyl市场价值将达23.6亿美元，2025年将达24.7亿美元，复合年增长率为4.66%，到2030年将达到31.1亿美元。

主要市场统计数据
基准年2024年 23.6亿美元
预计2025年 24.7亿美元
预测年份 2030 31.1亿美元
复合年增长率（%） 4.66%

在快速变化的製药业中，Fentanyl市场因临床需求和法律规范之间的复杂相互作用而受到广泛关注。近年来，在创新医疗应用和日益增长的研究倡议的推动下，这一领域经历了重大变化。Fentanyl使用的动态性质反映了更广泛的趋势，包括不断变化的患者需求、正在进行的临床试验以及对安全性和有效性标准的认识的提高。这个多边市场现在需要仔细重新考虑定价压力、竞争差异化和技术进步的快速步伐。

日益严格的审查迫使产业负责人不仅要关注药物传递的传统方面，还要关注将影响疼痛管理、麻醉和临终关怀未来的变革性变化。本研究深入检验了影响Fentanyl发展轨迹的关键市场驱动因素、挑战和机会。我们的分析着重可靠的数据、关键见解和策略预测，深入研究细微的市场动态和新兴的法律规范，为决策者和行业专业人士提供全面的观点。透过将这些关键问题置于更广泛的背景中，本报告旨在成为日益激烈的竞争环境中明智的决策的权威指南和催化剂。

Fentanyl市场的转型

Fentanyl市场的发展具有一系列变革性变化的特点，强调适应新的临床、监管和技术驱动因素。近年来，创新药物输送系统和加强安全通讯协定的投资不断增加，导致研究重点明显调整，市场动态也发生转变。先进配方和替代给药途径的引入不仅拓宽了治疗应用，而且还为改善患者依从性和治疗效果提供了途径。

政策改革和更严格的法规环境正在促使公司重新调整策略，特别是在谨慎管理医疗用途和潜在滥用之间的平衡方面。对永续供应链和品质保证的重新重视正在推动市场参与企业投资于尖端製造流程和风险缓解技术。这种持续的演变鼓励相关人员采用新技术并加强伙伴关係，同时培养一个创新与负责任使用并进的生态系统。

这些发展反映出该行业越来越倾向于精准驱动的应用，并扩大范围以考虑整个病人历程。随着医疗保健专业人员和创新者继续合作，整体效果将是一个更灵活、反应更快的市场，更适合满足即时的临床需求和长期趋势。

推动市场动态的关键细分洞察

仔细观察市场就会发现，多层次的细分凸显了Fentanyl市场的多样性与专业化。根据产品类型，正在考虑多种剂型，从注射剂到创新的锭剂和锭剂，以及滴鼻剂和经皮吸收贴片。产品的多样性使医疗专业人员能够针对不同的临床情况选择最佳解决方案，无论是即时介入还是持续照护。

就给药途径而言，市场分为口服、肠外和经皮途径。每条道路都有其自身的优势和挑战，这将影响整体市场份额和创新重点。此外，在应用细分方面，分析分为医疗和研发两大领域。在医疗用途方面，它进一步细分为麻醉、疼痛管理和安宁疗护等重要子类别，突显了药物在临床环境中的多功能性。

最后，了解分销管道将突出在医院、药局和零售药局等各个关键点进行的研究。这种强大的细分框架不仅揭示了特定的市场驱动因素，而且还支持更有针对性的策略规划和有针对性的投资。它还有助于深入了解每个环节如何为整个价值链做出贡献，使相关人员能够根据精细的消费者和临床需求发现成长、创新和伙伴关係的机会。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性疼痛的发生率不断上升，对有效疼痛管理的需求也日益增加
      • 术后和急性护理环境中对强效疼痛管理解决方案的需求不断增加
      • 增加医疗保健投资和政府措施以改善疼痛管理
    • 限制因素
      • 与Fentanyl相关的监管调查和公共卫生问题
    • 机会
      • 引进预填充式注射器，方便随时给药
      • 开发防止滥用的Fentanyl製剂，以提高安全性并扩大医疗用途
    • 任务
      • Fentanyl的非法生产和分销
  • 市场区隔分析
    • 产品类型：注射剂因其快速起效的特性而日益普及
    • 给药途径：口服给药是治疗慢性疼痛的首选非侵入性方法
    • 分销管道：医院药房Fentanyl在急性和手术全期疼痛管理的应用
    • 用途：扩大Fentanyl的医疗用途，芬太尼具有快速起效和强效止痛的特性
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章Fentanyl市场（依产品类型）

  • 介绍
  • 注射
  • 锭剂和锭剂
  • 鼻喷剂
  • 修补

第七章Fentanyl市场（依给药途径）

  • 介绍
  • 口服
  • 肠外
  • 经皮

第八章Fentanyl市场（按应用）

  • 介绍
  • 医疗用途
    • 麻醉
    • 疼痛管理
    • 安宁疗护
  • 研究与开发

第九章Fentanyl市场通路

  • 介绍
  • 医院药房
  • 零售药局

10.美洲Fentanyl市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区Fentanyl市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲Fentanyl市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Alvogen
  • Apotex Inc.
  • Biesterfeld SE
  • Daiichi Sankyo Company, Limited
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Humanwell Healthcare（Group）Co., Ltd.
  • Kyowa Hakko Kirin Co. Ltd.
  • Mallinckrodt plc
  • Nutriband Inc.
  • Pfizer Inc.
  • Piramal Pharma Limited
  • QuVa Pharma, Inc
  • SCA Pharma
  • Spectrum Chemical Mfg. Corp.
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Tofigh Daru Research & Engineering Company
  • Verve HumanCare Laboratories
  • Viatris Inc.
Product Code: MRR-CB04E056533E

The Fentanyl Market was valued at USD 2.36 billion in 2024 and is projected to grow to USD 2.47 billion in 2025, with a CAGR of 4.66%, reaching USD 3.11 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.36 billion
Estimated Year [2025] USD 2.47 billion
Forecast Year [2030] USD 3.11 billion
CAGR (%) 4.66%

In the ever-evolving world of pharmaceuticals, the fentanyl market has garnered significant attention due to its complex interplay between clinical demand and regulatory oversight. Over recent years, this sector has experienced considerable shifts driven by both innovative medical applications and growing research initiatives. The dynamic nature of fentanyl usage reflects broader trends that include evolving patient needs, ongoing clinical trials, and heightened awareness of safety and efficacy standards. This multifaceted market now demands a careful reexamination of price pressures, competitive differentiation, and the rapid pace of technological advancements.

Amid heightened scrutiny, industry researchers are tasked with exploring not only the conventional aspects of drug delivery but also the transformative shifts shaping the future of pain management, anesthesia, and end-of-life care. This study provides a meticulous examination of key market drivers, challenges, and opportunities that currently influence the trajectory of fentanyl. Emphasizing reliable data, critical insights, and strategic forecasts, the analysis delves into nuanced market dynamics and emerging regulatory frameworks to offer a comprehensive perspective for decision-makers and industry experts. By framing these key issues within a broader context, this report aims to serve as both a definitive guide and a catalyst for informed decision-making in an increasingly competitive landscape.

Transformative Shifts in the Fentanyl Market Landscape

The evolving nature of the fentanyl market has been marked by a series of transformative shifts that underscore its adaptation to new clinical, regulatory, and technological drivers. In recent years, there has been a discernible realignment of research focus and a shift in market dynamics fueled by increasing investments in innovative drug delivery systems and enhanced safety protocols. The introduction of advanced formulations and alternative routes of administration has not only broadened therapeutic applications but has also provided avenues for improved patient compliance and outcomes.

Policy reforms and a more rigorous regulatory environment have spurred companies to recalibrate their strategies, especially as the balance between medical use and potential misuse is carefully managed. With a renewed emphasis on sustainable supply chains and quality assurance, market participants are now investing in state-of-the-art manufacturing processes and risk mitigation techniques. This ongoing evolution has pushed stakeholders to embrace novel technologies and robust partnerships, while also fostering an ecosystem where innovation and responsible use go hand in hand.

These developments reflect an industry increasingly inclined toward precision-based applications and an expanded scope that takes into account the entirety of the patient journey. As practitioners and innovators continue to work in tandem, the overall impact is a more agile, responsive market that is better equipped to tackle both immediate clinical needs and long-term trends.

Key Segmentation Insights Driving Market Dynamics

A detailed examination of the market reveals several layers of segmentation that highlight both the diversity and specialization within the fentanyl sector. The product type segmentation examines formulations ranging from injectables to innovative lozenges and tablets, alongside nasal sprays and transdermal patches - each reflecting unique delivery mechanisms tailored to distinct therapeutic needs. This spectrum of products enables healthcare professionals to choose solutions that best fit different clinical scenarios, whether for immediate intervention or sustained care.

When looking at the route of administration, the market is dissected across oral, parenteral, and transdermal pathways. Each method carries its own set of benefits and challenges, influencing the overall market share and innovation focus. Additionally, the application segmentation bifurcates the analysis into medical use and research and development. Within medical use, there is a further breakdown into critical sub-categories including anesthesia, pain management, and palliative care, underlining the drug's versatility in clinical settings.

Finally, an understanding of the distribution channel reveals studies conducted across various critical points including hospitals, pharmacies, and retail pharmacies. This robust segmentation framework not only sheds light on specific market drivers but also supports more tailored strategic planning and targeted investment. It facilitates insight into how each segment contributes to the overall value chain, enabling stakeholders to identify opportunities for growth, innovation, and partnership based on refined consumer and clinical needs.

Based on Product Type, market is studied across Injectables, Lozenges & Tablets, Nasal Sprays, and Patches.

Based on Route of Administration, market is studied across Oral, Parenteral, and Transdermal.

Based on Application, market is studied across Medical Use and Research & Development. The Medical Use is further studied across Anesthesia, Pain Management, and Palliative Care.

Based on Distribution Channel, market is studied across Hospitals Pharmacies and Retail Pharmacies.

Key Regional Insights Shaping Market Opportunities

Geographic analysis of the fentanyl market demonstrates distinct regional nuances that are instrumental in shaping both current dynamics and future opportunities. In the Americas, the market has shown a progressive shift driven by advanced healthcare infrastructure and evolving treatment protocols, which in turn have spurred rapid adoption of new formulations and innovative delivery methods. Regulatory frameworks in these regions support a robust yet controlled market environment, ensuring that clinical efficacy and safety remain paramount.

The landscape in Europe, the Middle East, and Africa underscores a complex interplay between established healthcare systems and emerging markets. In these regions, traditional healthcare practices are increasingly complemented by cutting-edge technologies and research-driven innovations. This blend of historical strength and novel approaches has led to renewed interest in comprehensive market strategies. Similarly, the Asia-Pacific area, characterized by accelerated economic development and increasing healthcare spending, has emerged as a significant player. Rapid urbanization, enhanced patient access, and expanding clinical capabilities have all contributed to a dynamic market environment. The regional insights provide a holistic view of how local socio-economic factors and regulatory policies can drive both competition and collaboration on a global scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights and Industry Leaders

The fentanyl market is not only defined by evolving therapeutic areas and product innovation, but also by a competitive landscape dominated by a cohort of established industry players. In this arena, several companies have distinguished themselves by offering proprietary technologies and streamlined operations. Leading companies ranging from global innovators to specialized firms have propelled the momentum of the market through strategic investments in R&D and robust commercial networks. These include players such as Alvogen, Apotex Inc., Biesterfeld SE, and Daiichi Sankyo Company, Limited, whose commitment to research and comprehensive clinical adoption has fostered progress across the board.

Additional industry trailblazers like Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, and Humanwell Healthcare (Group) Co., Ltd. have contributed significantly to shaping the market through their persistent focus on innovation and quality improvement. This competitive group is further enriched by the presence of companies such as Kyowa Hakko Kirin Co. Ltd., Mallinckrodt plc, Nutriband Inc., and Pfizer Inc., each bringing a unique perspective and diversified portfolio to the field. Noteworthy efforts by Piramal Pharma Limited, QuVa Pharma, Inc., SCA Pharma, Spectrum Chemical Mfg. Corp., Terumo Corporation, Teva Pharmaceutical Industries Ltd., Tofigh Daru Research & Engineering Company, Verve HumanCare Laboratories, and Viatris Inc. also highlight an industry driven by vigorous competition, technological advancements, and an unwavering commitment to quality. Together, these companies not only shape market standards but also stimulate an environment of continuous improvement and strategic realignment.

The report delves into recent significant developments in the Fentanyl Market, highlighting leading vendors and their innovative profiles. These include Alvogen, Apotex Inc., Biesterfeld SE, Daiichi Sankyo Company, Limited, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Humanwell Healthcare (Group) Co., Ltd., Kyowa Hakko Kirin Co. Ltd., Mallinckrodt plc, Nutriband Inc., Pfizer Inc., Piramal Pharma Limited, QuVa Pharma, Inc, SCA Pharma, Spectrum Chemical Mfg. Corp., Terumo Corporation, Teva Pharmaceutical Industries Ltd., Tofigh Daru Research & Engineering Company, Verve HumanCare Laboratories, and Viatris Inc.. Actionable Recommendations for Industry Leaders in Fentanyl

For industry leaders seeking to navigate the complexities of the fentanyl market and harness growth opportunities, several actionable recommendations stand out. First and foremost, it is crucial to maintain a proactive approach by investing in innovative delivery systems and advanced formulation technologies. Empowering research initiatives can lead to more efficacious and safer therapeutic options that meet stringent clinical requirements and regulatory standards.

Leaders should also focus on bolstering their presence across key distribution channels. Strategic alliances with hospitals, pharmacies, and retail networks can ensure broader market penetration and diversified revenue streams. In addition, a continuous review of product portfolios - especially with respect to different routes of administration such as oral, parenteral, and transdermal - can yield insights that align clinical performance with market expectations.

A sharp focus on regional dynamics is equally critical. With distinctive market conditions in the Americas, Europe, the Middle East & Africa, and Asia-Pacific, tailored regional strategies are essential. Investment in localized research and market-specific promotions helps in addressing unique consumer demands and regulatory challenges. Finally, fostering collaborative partnerships across the value chain, from R&D to distribution, will not only drive innovation but also create sustainable competitive advantages in an increasingly dynamic environment. These recommendations, when implemented effectively, can serve as a robust framework to enhance market positioning and drive long-term growth.

Conclusion: Strategic Reflections on Fentanyl Market Trends

In summary, the analysis of the fentanyl market underscores a period of significant transformation marked by dynamic innovation, evolving regulatory frameworks, and an increasingly segmented market structure. The interplay between advanced drug formulations, sophisticated routes of administration, and diversified applications has fueled a vibrant competitive landscape. Regional variations further accentuate differences in market maturity, offering unique insights into both growth potentials and strategic challenges that span global markets.

This comprehensive review highlights the necessity for industry stakeholders to adopt forward-looking strategies that balance innovation with prudent risk management. The evolving nature of clinical needs, paired with rapid technological advancements, calls for a persistent reevaluation of market strategies to meet the demands of a complex healthcare environment. Ultimately, this reflective overview serves as a call to industry leaders to embrace change and pursue opportunities that align with emerging trends and consumer expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic pain conditions with the need for effective pain management
      • 5.1.1.2. Growing demand for potent pain management solutions in post-surgical and acute care settings
      • 5.1.1.3. Increased healthcare investments and government initiatives aimed at improving pain management
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory scrutiny and public health concerns associated with fentanyl
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of ready-to-administer prefilled fentanyl syringes
      • 5.1.3.2. Development of abuse-deterrent fentanyl formulations to enhance safety and expand medical use
    • 5.1.4. Challenges
      • 5.1.4.1. Illicit production and distribution of fentanyl
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing adoption of injectables due to their immediate onset of action
    • 5.2.2. Route of Administration: Preference for oral route of administration for non-invasive option for chronic pain management
    • 5.2.3. Distribution Channel: Utilization of fentanyl in hospitals pharmacies in managing acute and perioperative pain
    • 5.2.4. Application: Expanding application of fentanyl in medical use for its rapid onset and potent analgesic properties.
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fentanyl Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injectables
  • 6.3. Lozenges & Tablets
  • 6.4. Nasal Sprays
  • 6.5. Patches

7. Fentanyl Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parenteral
  • 7.4. Transdermal

8. Fentanyl Market, by Application

  • 8.1. Introduction
  • 8.2. Medical Use
    • 8.2.1. Anesthesia
    • 8.2.2. Pain Management
    • 8.2.3. Palliative Care
  • 8.3. Research & Development

9. Fentanyl Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals Pharmacies
  • 9.3. Retail Pharmacies

10. Americas Fentanyl Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Fentanyl Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Fentanyl Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Nephron Pharmaceuticals invests USD 10 million to expand BFS manufacturing capacity for advanced drug formulations
    • 13.3.2. Hikma Pharmaceuticals introduces new fentanyl citrate injections for advanced pain management in clinical settings
    • 13.3.3. The University of Montana and corporate partners advance NIH-funded preclinical studies on novel fentanyl and heroin vaccines
    • 13.3.4. Fresenius Kabi launches a new 100 mcg per 2 mL fentanyl citrate prefilled syringe to enhance patient safety
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Nutriband Inc.
    • 13.4.2. Hikma Pharmaceuticals PLC
    • 13.4.3. Teva Pharmaceutical Industries Ltd.
    • 13.4.4. Pfizer Inc.

Companies Mentioned

  • 1. Alvogen
  • 2. Apotex Inc.
  • 3. Biesterfeld SE
  • 4. Daiichi Sankyo Company, Limited
  • 5. Fresenius SE & Co. KGaA
  • 6. Hikma Pharmaceuticals PLC
  • 7. Humanwell Healthcare (Group) Co., Ltd.
  • 8. Kyowa Hakko Kirin Co. Ltd.
  • 9. Mallinckrodt plc
  • 10. Nutriband Inc.
  • 11. Pfizer Inc.
  • 12. Piramal Pharma Limited
  • 13. QuVa Pharma, Inc
  • 14. SCA Pharma
  • 15. Spectrum Chemical Mfg. Corp.
  • 16. Terumo Corporation
  • 17. Teva Pharmaceutical Industries Ltd.
  • 18. Tofigh Daru Research & Engineering Company
  • 19. Verve HumanCare Laboratories
  • 20. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. FENTANYL MARKET MULTI-CURRENCY
  • FIGURE 2. FENTANYL MARKET MULTI-LANGUAGE
  • FIGURE 3. FENTANYL MARKET RESEARCH PROCESS
  • FIGURE 4. FENTANYL MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL FENTANYL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FENTANYL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES FENTANYL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. FENTANYL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. FENTANYL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FENTANYL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FENTANYL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FENTANYL MARKET DYNAMICS
  • TABLE 7. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FENTANYL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. FENTANYL MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 236. FENTANYL MARKET, FPNV POSITIONING MATRIX, 2024